CGEM - Company ID 0001789972
As of 2026-11-06, Cullinan Therapeutics, Inc. (CGEM) has a market capitalization of $713.69 M, making it the #2609 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $713.69 M |
| 2026-11-05 | $695.03 M |
| 2026-11-04 | $796.07 M |
| 2026-11-03 | $1.01 B |
| 2026-11-02 | $960.82 M |
| 2026-11-01 | $923.71 M |
| 2026-10-31 | $923.71 M |
| 2026-10-30 | $918.18 M |
| 2026-10-29 | $949.53 M |
| 2026-10-28 | $943.69 M |
| 2026-10-27 | $913.27 M |
| 2026-10-26 | $893.60 M |
As of 2026-11-06, Cullinan Therapeutics, Inc. (CGEM) has a market capitalization of $713.69 M, making it the #2609 most valuable US-listed company.
Cullinan Therapeutics, Inc. is the #2609 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $883.15 M |
| 2026-10-24 | $883.15 M |
| 2026-10-23 | $883.15 M |
| 2026-10-22 | $914.19 M |
| 2026-10-21 | $915.11 M |
| 2026-10-20 | $911.42 M |
| 2026-10-19 | $859.18 M |
| 2026-10-18 | $794.65 M |
| 2026-10-17 | $794.65 M |
| 2026-10-16 | $794.65 M |
| 2026-10-15 | $857.95 M |
| 2026-10-14 | $838.29 M |
| 2026-10-13 | $866.56 M |
| 2026-10-12 | $918.80 M |
| 2026-10-11 | $954.44 M |
| 2026-10-10 | $954.44 M |
| 2026-10-09 | $954.44 M |
| 2026-10-08 | $950.14 M |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.